🔎 Trials Near Me

Akèy › Sindrom Sjogren › Texas › Houston

Etid klinik pou Sindrom Sjogren nan Houston, TX

6 etid pou Sindrom Sjogren ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

Ap rekriteFaz 3
  • Abigail Neiman MD PA, Houston
  • Novel Research LLC, Bellaire · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07621809

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

Ap rekriteFaz 2
  • Novel Research LLC, Bellaire · 7 mi lwen
Laj 18 a 100 · Tout sèks · Mizajou Sep 25, 2026 · NCT07737743

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • UT MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

Ap rekriteFaz 3
  • Accurate Clinical Research, Inc., Houston
  • Novel Research LLC, Bellaire · 7 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Aug 27, 2026 · NCT07404865

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Ap rekriteFaz 2
  • Artiva Investigational Site Bellaire, Bellaire · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06991114

The Myelin Disorders Biorepository Project

Ap rekriteEtid obsèvasyon
  • Baylor College of Medicine (Texas Children's Hospital), Houston
  • UT Health Houston, Houston
Tout laj · Tout sèks · Mizajou Oct 23, 2025 · NCT03047369

Etid Sindrom Sjogren nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.